• 1
    UK National Screening Committee. Available at:, accessed 11 July 2011.
  • 2
    Levy HL. Newborn screening by tandem mass spectrometry: a new era. Clinical Chemistry, 1998; 44: 24012402.
  • 3
    Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva: World Health Organisation, 1968.
  • 4
    Bijarnia S, Wiley V, Carpenter K, Christodoulou J, Ellaway C, Wilcken B. Glutaric aciduria type I: outcome following detection by newborn screening. Journal of Inherited Metabolic Disease, 2008; 31: 503507.
  • 5
    Vockley J, Ensenauer R. Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity† American Journal of Medical Genetics Part C: seminars in Medical Genetics. Special Issue: Inborn Errors of Metabolism, 2006; 142C: 95103.
  • 6
    Chrastina P, St’astna S, Myskova H, Kosarova M, Elleder M, Zeman J. Newborn screening of inherited metabolic disorders by tandem mass spectrometry. Klinicka Biochemie a Metabolismus, 2005; 13: 7780.
  • 7
    Autti-Ramo I, Makela M, Sintonen H et al. Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland. Acta Paediatrica, International Journal of Paediatrics, 2005; 94: 11261136.
  • 8
    den Boer ME, Wanders RJ, Morris AA, IJlst L, Heymans HS, Wijburg FA. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics, 2002; 109: 99104.
  • 9
    UK National Screening Committee Second report of the National Screening Committee, 2002. Available at:, accessed 11 July 2011.
  • 10
    Medical Research Council Human tissue and biological samples for use in research. Operational and Ethical Guidelines, 2001. Available at:, accessed 11 July 2011.
  • 11
    Bailey DB, Skinner D, Davis AM, Whitmarsh I, Powell C. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues. Pediatrics, 2008; 121: 693704.
  • 12
    Hargreaves KM, Stewart RJ, Oliver SR. Informed choice and public health screening for children: the case of blood spot screening. Health Expectations, 2005; 8: 161171.
  • 13
    Stewart R, Oliver S. What is known about communication with parents about newborn blood spot screening? UK Newborn Screening Programme Centre. London, 2003. Available at:, accessed 11 July 2011.
  • 14
    Pollitt RJ, Green A, McCabe A et al. Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess, 1997; 1: i–iv, 1202.
  • 15
    Chadwick R, ten Have H, Husted J et al. Genetic screening and ethics: European perspectives. Journal of Medical Philosophy, 1998; 23: 255273.
  • 16
    Stewart F. Ethics of newborn screening. Current Paediatrics, 2006; 16: 216220.
  • 17
    Kemper AR, Fant KE, Clark SJ. Informing parents about newborn screening. Public Health Nursing, 2005; 22: 332338.
  • 18
    El-Wakeel H, Taylor GJ, Tate JJT. What do patients really want to know in an informed consent procedure? A questionnaire-based survey of patients in the Bath area, UK. Journal of Medical Ethics, 2006; 32: 612616.
  • 19
    Østerlie W, Solbjør M, Skolbekken J-A, Hofvind S, Sætnan AR, Forsmo S. Challenges of informed choice in organised screening. Journal of Medical Ethics, 2008; 34: e5.
  • 20
    Arnold CL, Davis TC, Frempong JO et al. Assessment of newborn screening parent education materials. Pediatrics, 2006; 117 (5 Pt 2): S320S325.
  • 21
    Cooke RW. Good practice in consent. Seminars In Fetal & Neonatal Medicine, 2005; 10: 6371.
  • 22
    Helgesson G, Swartling U. Views on data use, confidentiality and consent in a predictive screening involving children. Journal of Medical Ethics, 2008; 34: 206209.
  • 23
    O’Neill O. Autonomy and Trust in Bioethics. Cambridge: Cambridge University Press, 2002.
  • 24
    Helgesson G, Ludvigsson J, Gustafsson Stolt U. How to handle informed consent in longitudinal studies when participants have a limited understanding of the study. Journal of Medical Ethics, 2005; 31: 670673.
  • 25
    Tarini BA, Wylie Burke W, Scott RC, Wilfon BS. Waiving informed consent in newborn screening research: Balancing social value and respect. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2008; 148C: 2230.
  • 26
    Junghans C, Feder G, Harry Hemingway H, Timmis A, Jones M. Recruiting patients to medical research: blind randomised trial of “opt-in” versus double “opt-out” strategies. British Medical Journal, 2005; 331: 940.
  • 27
    Rogers CG, Tyson E, Kennedy KA, Broyles RS, Hickman JF. Conventional consent with opting in versus simplified consent with opting out: an exploratory trial for studies that do not increase patient risk. Journal of Pediatrics, 1998; 132: 606611.
  • 28
    Liebl B, Nennstiel-Ratzel U, von Kries R et al. Very high compliance in an expanded MS-MS-based newborn screening program despite written parental consent. Preventative Medicine, 2002; 34: 127131.
  • 29
    Davis TC, Humiston SG, Arnold CL et al. Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts. Pediatrics, 2006; 117 (5 Pt 2): S326S340.
  • 30
    Davey A, French D, Dawkins H, O’Leary P. New mothers’ awareness of newborn screening, and their attitudes to the retention and use of screening samples for research purposes. Genomics, Society and Policy, 2005; 1: 4151.
  • 31
    Detmar S, Hosli E, Dijkstra N, Nijsingh N, Rijnders M, Verweij M. Information and Informed Consent for Neonatal Screening: opinions and Preferences of Parents. Birth, 2007; 34: 238244.
  • 32
    Detmar S, Dijkstra N, Nijsingh N, Rijnders M, Verweij M, Hosli E. Parental Opinions about the Expansion of the Neonatal Screening Programme. Community Genetics, 2008; 11: 1117.
  • 33, accessed 11 July 2011.
  • 34
    UK Newborn Screening Programme Centre Newborn blood spot screening for your baby. Available at:, accessed 11 July 2011.
  • 35
    Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology, 2006; 3: 77101.
  • 36
    Ponder M, Statham H, Hallowell N, Moon JA, Richards M, Raymond FL. Genetic research on rare familial disorders: consent and the blurred boundaries between clinical service and research. Journal of Medical Ethics, 2008; 34: 690694.